Evidence map›Paper›PMID 36506022›Full record

ArticleFrontiers in cellular and infection microbiology2022

Editorial: Otitis media.

Kevin M Mason, Robyn L Marsh, Stephen I Pelton, Eric T Harvill

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kevin M MasonCenter for Microbial Pathogenesis, The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, United States.
Robyn L MarshChild Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, NT, Australia.
Stephen I PeltonBoston University Chobanian & Avedisian School of Medicine, Boston, MA, United States.
Eric T HarvillDepartment of Infectious Diseases, College of Veterinary Medicine, University of Georgia, Athens, GA, United States.

Funding

Are acellular vaccines driving the rise of pertactin-deficient Bordetella pertussisR21AI156293 · NIAID · UNIVERSITY OF GEORGIA · PI HARVILL, ERIC T · 2021 to 2022
$415k
Protection against Bordetella pertussis transmission conferred by established and novel vaccinesR21AI159347 · NIAID · UNIVERSITY OF GEORGIA · PI HARVILL, ERIC T · 2021 to 2022
$415k
Bacterial factors and host response in chronic otitis mediaR21DC018496 · NIDCD · UNIVERSITY OF GEORGIA · PI HARVILL, ERIC T · 2020 to 2021
$415k
An optimized mouse model of Bordetella pertussis infectionR21AI142678 · NIAID · UNIVERSITY OF GEORGIA · PI HARVILL, ERIC T · 2019 to 2020
$414k
Vaccine targeting catarrhal stage of pertussis diseaseR56AI149787 · NIAID · UNIVERSITY OF GEORGIA · PI HARVILL, ERIC T · 2020 to 2020
$369k
NIAID NIH HHS R21 AI142678NIAID NIH HHS R21 AI156293NIAID NIH HHS R21 AI159347NIAID NIH HHS R56 AI149787NIDCD NIH HHS R21 DC018496
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

childhood diseasedeafnessdiagnosishearingimmunityotitis mediapathogenesisvaccine

Identifiers

PMID36506022
PMCPMC9733949

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.